Used in pharmaceutical synthesis as an intermediate for kinase inhibitors, particularly in the development of anticancer agents. Its structure supports binding to enzyme active sites, enhancing selectivity and potency. Commonly employed in the preparation of targeted therapies for solid tumors and hematological malignancies. Also utilized in research settings to design novel bioactive molecules with improved metabolic stability and pharmacokinetic profiles.